Machine Intelligence Evaluation of Pathology Specimens
Dr. Doggett is an early adopter of a new technology called "systems pathology". Patients' existing pathology specimens are examined at a highly specialized laboratory with a computer utilizing pattern recognition technology and machine intelligence. Multiple different stains for specific molecular cancer markers, such as the androgen receptor, are evaluated and ranked according to computer specified parameters. This information is compared against a library of prostate cancer specimens from over 1000 patients who have been followed for over eight years. This comparison allows Dr. Doggett to more accurately determine which patients are at higher risk of cancer spread outside of the prostate and will benefit from additional therapy such as external beam radiation, chemotherapy and hormone therapy. The comparison also permits elimination of additional therapy such as external beam radiation, chemotherapy and hormone therapy in patients that the comparison shows are at low risk of cancer spread outside of the prostate.
For more information on the machine intelligence technology that Dr. Doggett uses, click here http://www.aureon.com/